Despair: Blood Curse

Crimson Sequence · 2024 · $11.99 · Action · deal grade B

Measured on 2026-09-26 15:04 UTC, 9 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $187 to $281 per month
• Opportunity: $374 per month at x1.60 dormancy
• Estimated lifetime owners: 5.5k
• 82% positive across 154 reviews · 2.7 reviews/month

Why it's flagged

• Developer silent for 2.6 years
• Studio quiet across its whole catalog

Analyst notes (AI-assisted)

Note written 2026-09-19; the live figures above take precedence over any numbers in it.

A short, survival-horror action game released in 2024 that draws inspiration from classic franchises like Resident Evil and Silent Hill.

Despair: Blood Curse shows solid fundamentals: an 82% positive review rate, multi-language support, and consistent micro-residuals ($234/mo mid-range) from a tiny but stable player base. However, the studio is fading, the game has never run a discount, and the community explicitly flags pricing friction relative to content depth. This is a watch candidate rather than an acquisition target unless the rights holder is open to aggressive repricing or marketing revival; the IP remains proprietary but the attached opportunity is modest. Most realistic play: watch.

• Risk: Player sentiment has declined 9.7 points in recent months despite a 71% recent positive rate, suggesting initial enthusiasm is waning.
• Risk: Studio status is fading with no developer communication for 30 months and only one title in catalog, raising sustainability concerns.
• Risk: Zero concurrent players and single-digit monthly peaks indicate the game may not have viable multiplayer or social-loop mechanics to drive retention.

This case as Markdown · Estimates carry ±30-50% error per title.